Oxford Finance Closes $25MM Term Loan for Karius

Oxford Finance closed a $25 million senior secured term loan with Karius, a life science company focused on transforming infectious disease diagnostics with genomics.

Oxford Finance Supports Sheridan Investment in Empower PT

Oxford Finance provided debt financing to support Sheridan Capital Partners’ investment in Empower Physical Therapy, a physical therapy practice management company.

Oxford Finance Provides Credit Facility to Unitek Learning

Oxford Finance closed a senior credit facility for Unitek Learning, a portfolio company of Cressey & Company. Oxford served as the sole lender and administrative agent on the transaction.

SVB, Oxford Upsize Reata Pharmaceuticals Facility to $125MM

Reata Pharmaceuticals amended its loan and security agreement with Oxford Finance and Silicon Valley Bank, increasing the term loan facility from $45 million to $125 million.

Oxford Finance Upsizes Invitae Facility to $40MM

Invitae reached an agreement with Oxford Finance to expand its existing loan and security agreement by $20 million, bringing the total remaining capital available under the agreement to $40 million.

Oxford, SVB Provide $45MM for Nuvectra

Nuvectra, a neurostimulation medical device company, reached an agreement with Silicon Valley Bank and Oxford Finance, the lenders of its existing credit facility, to secure a second amendment to the company’s loan and security agreement for $45 million.

Oxford Finance Closes $300MM Senior Note Offering

Oxford Finance closed a $300 million senior unsecured note offering by Oxford and Oxford Finance Co-Issuer II, a wholly owned subsidiary of Oxford.

Oxford Finance Provides $20MM Debt Facility to VitalConnect

Oxford Finance closed a $20 million senior secured term loan with VitalConnect, a provider of wearable biosensor technology for wireless monitoring in hospital and remote patient populations.

Marathon Affiliates Provide $30MM Debt Refi to ADMA Biologics

ADMA Biologics entered into a credit agreement for up to $40 million with affiliated entities of Marathon Asset Management. The proceeds were used to refinance an outstanding secured loan with Oxford Finance.

SVB Provides $21MM Term Loan Facility to Selecta Biosciences

Selecta Biosciences entered into a term loan facility for up to $21 million with Silicon Valley Bank, which will be used partly to repay its existing term loan facility with Oxford Finance as agent.